Heart Health
Online heart health care: advanced heart labs and a live physician visit
VevaMD's online heart health visit pairs an advanced heart lab panel (ApoB, ApoA, hsCRP, LDL, HDL, total cholesterol, triglycerides, VLDL and bilirubin) with a live video visit. A board-certified, US-licensed physician reviews your cardiovascular risk and builds a plan that may include lifestyle changes, a generic statin such as atorvastatin or rosuvastatin, ezetimibe, or a brand-name GLP-1. A prescription is not guaranteed.
Coming soon · Price published before launch · A prescription is not guaranteed
- Status
- Coming soon. No intake is open yet.
- Price
- Not published yet. You see the full price before you pay.
- Visit
- A live video visit with a physician. Follow-ups may be online, without video.
- Labs
- A nine-marker heart panel: hsCRP, Total cholesterol, HDL, LDL, Triglycerides, VLDL, ApoB, ApoA, Total bilirubin.
- Treatment
- Lifestyle changes, a generic statin, ezetimibe, a brand-name GLP-1, or a mix. A prescription is not guaranteed.
- Prescriber
- Board-certified, US-licensed physicians. VevaMD does not prescribe.
- States
- Not open yet. The state list is not final.
- What's included
- The heart lab panel, a live physician video visit, and a plan made for you.
What the heart lab panel measures
A standard cholesterol test (a lipid panel) measures total cholesterol, LDL, HDL and triglycerides. This panel adds ApoB, ApoA-I, hsCRP, VLDL and bilirubin, so your physician sees more than the four usual numbers.
hsCRP
High-sensitivity C-reactive protein
Your liver makes C-reactive protein (CRP) in response to inflammation. The high-sensitivity test picks up very small increases in CRP and is used to estimate the risk of heart disease. It is not the same as a standard CRP test, which looks for infection and other inflammatory conditions.[6]
Total cholesterol
The total amount of cholesterol in your blood, including HDL and LDL. Your body needs some cholesterol to make hormones and vitamin D; your liver makes what you need and clears the excess.[1]
HDL
High-density lipoprotein cholesterol
Often called "good" cholesterol. HDL helps clear LDL cholesterol from your blood.[1]
LDL
Low-density lipoprotein cholesterol
Often called "bad" cholesterol. Too much LDL can build up as plaque in the arteries (atherosclerosis), which can narrow or block them. Blocked blood flow to the heart can cause a heart attack; to the brain, a stroke.[1]
Triglycerides
A type of fat in your blood. High triglyceride levels may increase the risk of heart disease.[2][1]
VLDL
Very-low-density lipoprotein cholesterol
Very-low-density lipoprotein, made by your liver. VLDL mainly carries triglycerides, while LDL mainly carries cholesterol. VLDL is not measured directly: labs estimate it from your triglycerides, at about one-fifth of the triglyceride level.[3]
ApoB
Apolipoprotein B
Apolipoprotein B is a protein that moves cholesterol around your body, and it is part of LDL. MedlinePlus notes that ApoB can give more detail about heart disease risk, even when cholesterol is at target. The 2026 ACC/AHA guideline says ApoB may be a more accurate risk marker than LDL in some groups, such as people with type 2 diabetes, high triglycerides or known cardiovascular disease who have reached their LDL and non-HDL goals.[4][9]
ApoA
Apolipoprotein A-I
Apolipoprotein A-I is a component of HDL. It helps move cholesterol out of the body’s tissues and into HDL, which carries it to the liver to be reused or removed.[5]
Total bilirubin
A yellowish substance made when your body breaks down old red blood cells. Your liver clears it into bile, so a bilirubin test is one way to check liver health.[7]
Lp(a) is not on this panel. Ask your physician about it at your visit.
How a physician assesses your cardiovascular risk
The PREVENT equations (American Heart Association)
Published by the American Heart Association in 2023, the PREVENT equations estimate 10-year and 30-year risk of cardiovascular disease, including atherosclerotic cardiovascular disease and heart failure, in adults 30 to 79 without known cardiovascular disease. They use routine measures: cholesterol, blood pressure, smoking, diabetes, medicines and kidney function (eGFR).[10][11]
The ACC CVD Risk Estimator Plus
The American College of Cardiology's calculator runs both the PREVENT equations and the older Pooled Cohort Equations, the original ASCVD risk estimator. It is meant for people who do not already have cardiovascular disease, and it can be re-run at follow-up visits.[11]
The 2026 ACC/AHA dyslipidemia guideline
The 2026 guideline replaces the 2018 cholesterol guideline. It recommends the PREVENT-ASCVD equations instead of the Pooled Cohort Equations for adults 30 to 79. It calls cholesterol-lowering therapy reasonable at a 10-year PREVENT-ASCVD estimate of 3% to under 5%, and recommends it at 5% to under 10% after a discussion between patient and physician. It also says Lp(a) should be measured at least once in adulthood.[9][8]
A risk score is a starting point. Your physician also weighs your lab panel, including ApoB and hsCRP, along with your weight, blood pressure, diabetes, smoking, family history and current medicines, then talks it through with you before anything is prescribed.
What a physician may prescribe
Your physician decides what, if anything, is appropriate: lifestyle changes alone, one medicine, or a combination. This table states no dose.
| Option | What it is | Status |
|---|---|---|
| Lifestyle changes | Food, activity, sleep and nicotine, set with your physician | No prescription |
| Atorvastatin | A statin. Oral tablet. The generic of Lipitor® | FDA-approved generic |
| Rosuvastatin | A statin. Oral tablet. The generic of Crestor® | FDA-approved generic |
| Lovastatin | A statin. Oral tablet | FDA-approved generic |
| Pravastatin | A statin. Oral tablet | FDA-approved generic |
| Ezetimibe | A non-statin that lowers the cholesterol your gut absorbs. Oral tablet. The generic of Zetia® | FDA-approved generic |
| A brand-name GLP-1 or GLP-1/GIP medication | A weight-management medicine. Which brand, and its form, depends on what your physician prescribes | FDA-approved brand |
What FDA labels and major trials say
Each medicine below is described from its FDA prescribing information and, where one exists, its cardiovascular outcome trial. Numbers are for the people those trials enrolled.
Wegovy® (semaglutide)
FDA label
FDA-approved in March 2024 to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal heart attack or nonfatal stroke) in adults with established cardiovascular disease and either obesity or overweight, alongside a reduced-calorie diet and more physical activity.[12][13]
The trial
In the SELECT trial, 17,604 adults aged 45 or older with existing cardiovascular disease, a BMI of 27 or higher and no diabetes took weekly semaglutide or placebo. Over a mean follow-up of 39.8 months, a first cardiovascular death, nonfatal heart attack or nonfatal stroke occurred in 6.5% of the semaglutide group and 8.0% of the placebo group (hazard ratio 0.80). Adverse events led 16.6% of the semaglutide group and 8.2% of the placebo group to stop the trial drug for good.[14]
Mounjaro® (tirzepatide)
FDA label
FDA-approved to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal heart attack or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events. Zepbound®, the same medicine approved for weight management, does not carry a cardiovascular indication.[15][16]
The trial
In the SURPASS-CVOT trial, 13,299 adults with type 2 diabetes and atherosclerotic cardiovascular disease were randomly assigned tirzepatide or dulaglutide, a GLP-1 already shown to reduce cardiovascular events. The primary cardiovascular end point occurred in 12.2% of the tirzepatide group and 13.1% of the dulaglutide group (hazard ratio 0.92). Tirzepatide was noninferior to dulaglutide; superiority was not shown.[17]
Atorvastatin (the generic of Lipitor®)
FDA label
FDA-labeled to reduce the risk of heart attack, stroke, revascularization procedures and angina in adults with multiple risk factors for coronary heart disease but no clinically evident heart disease, and of heart attack and stroke in adults with type 2 diabetes and multiple risk factors. It is also labeled to lower LDL cholesterol.[18]
Rosuvastatin (the generic of Crestor®)
FDA label
FDA-labeled to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal heart attack, nonfatal stroke or an arterial revascularization procedure) in adults at increased risk for these events, and to lower LDL cholesterol.[19]
The trial
In the JUPITER trial, 17,802 apparently healthy adults with LDL below 130 mg/dL and hsCRP of 2.0 mg/L or higher took rosuvastatin or placebo. The trial was stopped early, after a median 1.9 years: the combined primary end point occurred at 0.77 versus 1.36 events per 100 person-years (hazard ratio 0.56). Physician-reported diabetes was more common with rosuvastatin. JUPITER chose its participants by hsCRP, a marker on this panel.[20][19]
Ezetimibe (the generic of Zetia®)
FDA label
FDA-labeled to lower LDL cholesterol, with a statin or alone when other LDL-lowering therapy is not possible. Zetia's label lists LDL lowering, not a cardiovascular-event indication.[21]
The trial
In the IMPROVE-IT trial, 18,144 adults recently hospitalized for an acute coronary syndrome took simvastatin with ezetimibe or simvastatin with placebo. At 7 years, the primary cardiovascular end point had occurred in 32.7% of the ezetimibe group and 34.7% of the placebo group (hazard ratio 0.936).[22]
These are facts about specific medicines in the populations those trials enrolled. They are not a promise about your health, and naming a medicine here is not an offer of it. Your physician decides whether any of them is right for you, and outcomes differ from person to person.
How the online heart health visit works
- 1
Heart and metabolic intake
Answer private questions about your heart and metabolic health, family history, blood pressure, weight, smoking, activity and current medicines.
- 2
Advanced heart labs
A nine-marker panel: ApoB, ApoA, hsCRP, total cholesterol, LDL, HDL, triglycerides, VLDL and bilirubin.
- 3
Live video visit
A physician meets you by video, goes over your labs and history, and assesses your cardiovascular risk.
- 4
Your plan and follow-ups
Lifestyle changes, a statin, ezetimibe, a brand-name GLP-1, or a mix. Follow-ups may be online, and your plan is adjusted as your labs change.
Your care team
Who treats you
Every heart health intake, lab panel and video visit is reviewed by a board-certified, US-licensed physician licensed in your state. They make every prescribing decision. VevaMD never does.
Board-Certified Physicians
A board-certified physician reviews your intake and decides whether any prescription is appropriate. VevaMD is a technology company, not a medical provider.
Licensed in Your State
The physician who reviews your intake is licensed to practice in the state where you live.
You Meet Them on Live Video
Not a chatbot, and not a questionnaire-only approval. Every heart health visit starts with a live video visit with your physician.
VevaMD is a wellness technology platform. All medical services are delivered by independent board-certified physicians in our provider network.
How your visit works
Your video visit is a real appointment with a physician. Expect questions about your labs, your history, your family history and your goals. They may recommend lifestyle changes only, and a prescription is not guaranteed.
Who it may be for
- Adults who want a closer look at their heart labs than a standard cholesterol test gives.
- You have high cholesterol, a family history of early heart disease, excess weight, or high blood pressure, and want a physician to look at your cardiovascular risk.
- You want to talk with a physician about whether a statin, ezetimibe or a GLP-1 fits you.
- You are comfortable with a live video visit to start and online follow-ups after.
Only your physician can decide whether a medicine is appropriate. A prescription is not guaranteed.
Who it is not for
- Anyone with chest pain, shortness of breath, or signs of a heart attack or stroke right now. Call 911.
- People who need in-person or specialist cardiology care. Your physician may refer you.
- People who are pregnant, trying to conceive or breastfeeding: the 2026 ACC/AHA guideline defers most cholesterol-lowering medicines then.
- Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, if a GLP-1 is being considered.
Safety and side effects
- Statins can cause muscle pain, tenderness or weakness (myopathy) and, rarely, a serious muscle breakdown called rhabdomyolysis. Report unexplained muscle pain promptly. Liver enzyme increases can occur.[19][18]
- In JUPITER, diabetes was reported more often with rosuvastatin (2.8%) than with placebo (2.3%).[19]
- Common side effects of ezetimibe taken alone include upper respiratory infection, diarrhea, joint pain, sinusitis, pain in an arm or leg, and fatigue.[21]
- GLP-1 and GLP-1/GIP medicines carry a boxed warning: they caused thyroid C-cell tumors in rodents, and it is unknown whether they do in people. They are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Pancreatitis, gallbladder disease and stomach side effects, sometimes severe, have occurred.[13][15]
Report a side effect to FDA MedWatch. This is not emergency care. If you have chest pain, shortness of breath, or signs of a heart attack or stroke, call 911.
When and where it opens
The heart health visit is coming soon. Before the first visit opens, this page will show the price, the states where it is offered and how labs are collected. Until then there is nothing to sign up for or pay.
Common questions
Can I get a cholesterol test online?
VevaMD's heart health visit, opening soon, starts online: you complete a heart and metabolic intake, then do a nine-marker heart lab panel that goes beyond a standard cholesterol test, then meet a physician by live video to go over it. How the labs are collected will be published before the first visit opens.
What is an ApoB test?
An ApoB test measures apolipoprotein B, a protein that moves cholesterol around your body and is part of LDL. MedlinePlus notes it can give more detail about heart disease risk, even when cholesterol is at target, and the 2026 ACC/AHA guideline says ApoB may be a more accurate risk marker than LDL in some groups. ApoB is on this panel.
Is ApoB better than LDL?
They measure different things. LDL is the cholesterol carried in LDL particles; ApoB is a protein on those particles. The 2026 ACC/AHA guideline says ApoB may be a more accurate risk marker than LDL in people with type 2 diabetes, high triglycerides or known cardiovascular disease who have reached their LDL and non-HDL goals. This panel measures both.
What is an hsCRP test?
A high-sensitivity C-reactive protein test. Your liver makes CRP in response to inflammation, and the high-sensitivity test picks up very small increases. It is used to estimate the risk of heart disease. The JUPITER trial of rosuvastatin enrolled adults by an hsCRP of 2.0 mg/L or higher.
What does the heart lab panel include?
Nine markers: hsCRP, Total cholesterol, HDL, LDL, Triglycerides, VLDL, ApoB, ApoA, Total bilirubin. A standard lipid panel has four of them: total cholesterol, LDL, HDL and triglycerides.
Can I get a statin prescription online?
Yes, if a physician decides a statin is right for you after your labs and a live video visit. Options include generic atorvastatin, rosuvastatin, lovastatin and pravastatin, and the non-statin ezetimibe. A prescription is not guaranteed; your physician may recommend lifestyle changes only.
Which statins can a physician prescribe?
Atorvastatin, rosuvastatin, lovastatin and pravastatin, all FDA-approved generics. Ezetimibe, a non-statin, may be added or used instead. Your physician chooses the medicine and the dose.
What is an online heart health doctor visit like?
A live video appointment with a board-certified, US-licensed physician licensed in your state. They go over your heart labs, history, family history and goals, assess your cardiovascular risk, and recommend a plan. Follow-ups may be online, without video.
How does a physician assess my cardiovascular risk?
With the American Heart Association's PREVENT equations, which estimate 10- and 30-year risk for adults 30 to 79 without known cardiovascular disease, often run through the ACC's CVD Risk Estimator Plus, together with your lab panel, history and other risk factors. The 2026 ACC/AHA guideline recommends PREVENT over the older Pooled Cohort Equations.
Is Wegovy approved for heart health?
Wegovy® (semaglutide) is FDA-approved to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight. In the SELECT trial, those events occurred in 6.5% of the semaglutide group and 8.0% of the placebo group. Whether any GLP-1 is right for you is your physician’s decision.
Does tirzepatide have a heart indication?
Mounjaro® (tirzepatide) is FDA-approved to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes at high risk for them. In SURPASS-CVOT it was noninferior to dulaglutide, another GLP-1. Zepbound®, the same medicine approved for weight management, does not carry a cardiovascular indication.
Will I be prescribed a GLP-1?
Only if your physician decides it fits. A brand-name GLP-1 or GLP-1/GIP medication is one option alongside lifestyle changes, statins and ezetimibe, alone or combined.
Is a prescription guaranteed?
No. A physician reviews your labs and history and decides what, if anything, is right for you. Your physician may recommend lifestyle changes only.
How much does the heart health visit cost?
The price is not published yet. It will be on this page before the first visit opens, and you will see the full price before you pay.
Which states is it available in?
The heart health visit is not open yet, and the state list is not final. It will be published on this page before launch.
Is this emergency care?
This is not emergency care. If you have chest pain, shortness of breath, or signs of a heart attack or stroke, call 911.
Sources
- MedlinePlus (NIH). Cholesterol Levels.
- MedlinePlus (NIH). Triglycerides Test.
- MedlinePlus (NIH). VLDL Cholesterol.
- MedlinePlus (NIH). Apolipoprotein B.
- MedlinePlus Genetics (NIH). APOA1 gene.
- MedlinePlus (NIH). C-Reactive Protein (CRP) Test.
- MedlinePlus (NIH). Bilirubin Blood Test.
- Blumenthal RS, et al. 2026 ACC/AHA Guideline on the Management of Dyslipidemia. J Am Coll Cardiol. 2026;87(19):2624-2757.
- American College of Cardiology. ACC, AHA Release New Clinical Guideline for Managing Dyslipidemia. March 13, 2026.
- Khan SS, et al. Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024;149(6):430-449.
- American College of Cardiology. CVD Risk Estimator Plus.
- U.S. Food and Drug Administration. FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight. March 8, 2024.
- Wegovy® (semaglutide) prescribing information. DailyMed.
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232.
- Mounjaro® (tirzepatide) prescribing information. DailyMed.
- Zepbound® (tirzepatide) prescribing information. DailyMed.
- Nicholls SJ, et al. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes (SURPASS-CVOT). N Engl J Med. 2025;393(24):2409-2420.
- Lipitor® (atorvastatin) prescribing information. DailyMed.
- Crestor® (rosuvastatin) prescribing information. DailyMed.
- Ridker PM, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (JUPITER). N Engl J Med. 2008;359(21):2195-2207.
- Zetia® (ezetimibe) prescribing information. DailyMed.
- Cannon CP, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes (IMPROVE-IT). N Engl J Med. 2015;372(25):2387-2397.
- U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program.
Heart health care is coming soon
A licensed physician will review your labs and your history and decide whether treatment is right for you. You will see the price before you pay.
Last updated 2026-10-21. Content standards
Clinical care is provided by board-certified, US-licensed physicians. VevaMD Inc is a technology and marketing storefront only — not a medical provider or a pharmacy. Prescriptions are only issued if a licensed physician determines treatment is appropriate. This page is general information, not medical advice, and does not replace a visit with your own physician. Brand names are trademarks of their owners; VevaMD is not affiliated with them. Outcomes differ from person to person.